Jim Z. Wu

780 Cailun Road, Suite 701, ZhangJiang Hitech Park
Pudong, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Molecular mechanism of ziresovir targeting the fusion glycoprotein of respiratory syncytial virus.

Molecular mechanism of ziresovir targeting the fusion glycoprotein of respiratory syncytial virus.

Journal: PLoS pathogens

Published: September 07, 2025

Broad antifibrotic activities of AK3280 in pulmonary, hepatic, cardiac, and skin fibrosis animal models.

Broad antifibrotic activities of AK3280 in pulmonary, hepatic, cardiac, and skin fibrosis animal models.

Journal: International immunopharmacology

Published: December 12, 2024

Efficacy and safety of ziresovir in hospitalised infants aged 6 months or younger with respiratory syncytial virus infection in China: findings from a phase 3 randomised trial with 24-month follow-up.

Efficacy and safety of ziresovir in hospitalised infants aged 6 months or younger with respiratory syncytial virus infection in China: findings from a phase 3 randomised trial with 24-month follow-up.

Journal: The Lancet. Child & adolescent health

Published: November 11, 2024

Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection.

Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection.

Journal: The New England journal of medicine

Published: September 25, 2024

Establishing reference ranges of serum vitamin K in healthy children

Establishing reference ranges of serum vitamin K in healthy children

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: August 27, 2024

Novel small-molecule inhibitors of SARS-CoV-2 main protease with nanomolar antiviral potency.

Novel small-molecule inhibitors of SARS-CoV-2 main protease with nanomolar antiviral potency.

Journal: The Journal of infection

Published: December 12, 2023

Current state and challenges in respiratory syncytial virus drug discovery and development.

Current state and challenges in respiratory syncytial virus drug discovery and development.

Journal: Antiviral research

Published: November 21, 2023

Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial.

Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial.

Journal: Influenza and other respiratory viruses

Published: October 16, 2022

A multicenter epidemiological study of acute bacterial meningitis in children

A multicenter epidemiological study of acute bacterial meningitis in children

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: October 08, 2022

A multicenter study of the condition of children's rheumatic disease associated medical resources in Fujian province

A multicenter study of the condition of children's rheumatic disease associated medical resources in Fujian province

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: December 05, 2019

Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor.

Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor.

Journal: Journal of medicinal chemistry

Published: June 14, 2019

Application of the five-level pediatric emergency triage system: a single center study

Application of the five-level pediatric emergency triage system: a single center study

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: December 06, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026